About Zoetis India Limited
Data last updated:
Zoetis India Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Zoetis Pharmaceutical Research Private Limited. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 06 September 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46497MH2007PLC203686. Its GSTIN is 27AABCE8269K1Z5 (Maharashtra). The company holds 10 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹568.75 Cr and a paid-up capital of ₹13.5 Cr. It was formerly known as Vetnex Animal Health Private Limited and Vetnex Animal Health Limited. It is led by directors including Ashwini Shrikant Deshpande (Managing Director) and Jaydip Chatterjee (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 31 3rd Floor Kalpataru Synergy Opp. : Grand Hyatt Santacruz(E), Mumbai, Maharashtra, India – 400055.
As per the financials filed for FY 2025, the company reported a revenue of ₹402.08 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹28.72 Cr (net margin 7.1%) and EBITDA of ₹60.68 Cr (EBITDA margin 15.1%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 15% over five years.
The company has about 127 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Zoetis. As per MCA filings, the company has satisfied charges of ₹64.37 Cr on record. Court records list 90 cases involving the company, including 81 filed by the company and 8 filed against it; 6 cases are pending. The company has 5 deals on record (2 secondary share transfers, 2 acquisitions, 1 funding round), with disclosed funding of ₹6.58 Cr; the latest was in December 2012. Its 10 peer companies in the Pharma industry (Animal Pharma) are compared by revenue, 5 larger and 5 smaller; the largest is Virbac Animal Health India Private Limited with revenue of ₹1,358.25 Cr. The company has 9 MSME Form 1 returns on record between 2020 and 2024, listing 35 overdue payments to 14 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zoetis.in.
Name History of Zoetis India Limited
Zoetis India has undergone 5 name changes throughout its history. The current legal name is Zoetis India Limited.
| Company Name | Status |
|---|---|
| Zoetis India Limited | Current |
| Vetnex Animal Health Private Limited | Previous |
| Vetnex Animal Health Limited | Previous |
| Elegant E-Services Private Limited | Previous |
| Pfizer Animal Health India Limited | Previous |
| Vetnex Animal Health Limited | Previous |
CIN History of Zoetis India Limited
Zoetis India has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U46497MH2007PLC203686, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U46497MH2007PLC203686 | Current |
| U93000MH2007PLC203686 | Previous |
| U93000DL2007PLC167809 | Previous |
| U93000DL2007PTC167809 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address31 3rd Floor Kalpataru Synergy Opp. : Grand Hyatt Santacruz(E), Mumbai, Maharashtra, India – 400055
- IndustryPharma, Animal Pharmaceuticals & Healthcare
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Zoetis India Limited
Zoetis India operates one associated brand: Zoetis. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Animal medicines, vaccines, and diagnostics are manufactured and supplied. | zoetis.com |
Business Activity of Zoetis India Limited
The main business activity of Zoetis India is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Zoetis India Limited FY 2024 filings available
Zoetis India Limited reported revenue of ₹402.08 Cr (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Zoetis India Limited
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 30% growth in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Zoetis India Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹60.68 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹28.72 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Zoetis India Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Zoetis India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Zoetis India Limited
Zoetis India has 3 current directors and 24 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaydip Chatterjee | Whole-Time Director | 12 Sep 2022 | 4 Years 1 Months | Current |
| Ashwini Shrikant Deshpande | Managing Director | 30 Sep 2023 | 3 Years 0 Months | Current |
| Resha Mahabaleshwar Kantak | Whole-Time Director | 06 Apr 2012 | 14 Years 6 Months | Current |
Peer Comparison of Zoetis India Limited
Zoetis India Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Virbac Animal Health India Private Limited | ₹1,358.25 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Boehringer Ingelheim India Private Limited | ₹1,049.1 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Intervet India Private Limited | ₹696.24 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Pune, Maharashtra, India |
| Natural Remedies Private Limited | ₹548.65 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Bangalore, Karnataka, India |
| Fredun Pharmaceuticals Ltd Listed | ₹456.27 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
| Zoetis India Limited this company | ₹402.08 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Mumbai, Maharashtra, India |
| Alivira Animal Health Limited | ₹392.91 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
| NGL Fine-Chem Limited Listed | ₹376.89 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Zydus Animal Health and Investments Limited | ₹334.2 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Ahmedabad, Gujarat, India |
| Indian Herbs Specialities Private Limited | ₹315.14 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Saharanpur, Uttar Pradesh, India |
| Hester Biosciences Limited Listed | ₹315.03 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Mehsana, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Zoetis India by revenue in the Pharma industry (Animal Pharma), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Zoetis India Limited
Zoetis India Limited is audited by MSKA & Associates for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MSKA & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Zoetis India Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Zoetis India Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2009 | Icici Bank Limited | ₹7 Cr | Satisfied |
| 17 Aug 2009 | State Bank of India (Mid Corporate Loan Administrative Unit) | ₹33.33 Cr | Satisfied |
| 06 Aug 2009 | Yes Bank Limited | ₹17.51 Cr | Satisfied |
| 26 Sep 2003 | Indian Overseas Bank | ₹1.9 Cr | Satisfied |
| 26 Sep 2003 | Indian Overseas Bank | ₹4.63 Cr | Satisfied |
Total charge records: 5 View all charges
Deals & Funding of Zoetis India Limited
Zoetis India Limited has 5 deals on record (2 secondary share transfers, 2 acquisitions, 1 funding round), with disclosed funding of ₹6.58 Cr; the latest was in December 2012.
Deals on record (3 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2012 | Acquisition | ₹473.3 Cr | Buyer: Zoetis Pharmaceutical Research Private Limited |
| Jun 2009 | Funding round | ₹6.58 Cr | Investors: Icici Venture, Man GLG (GLG Partners), 2 individuals |
| Oct 2008 | Acquisition | Undisclosed | Buyer: Avantor Performance Materials India Private Limited Seller: 2 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Zoetis India Limited
Zoetis India Limited has 90 court cases on record: 81 filed by Zoetis India, 8 filed against it, 1 where it is another party. 6 cases are pending and 84 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 81 | 6 | 3 |
| High courts | 9 | 2 | 3 |
Cases on record (5 of 90)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed against the company by Arambagh Hatcheries Ltd | Disposed |
| Bombay High Court | Commercial suit | Filed against the company by Tara Enterprises | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| Bombay High Court | Court case (SJ) | Filed by the company against an individual | Pending |
| District court, Kanpur Nagar, Uttar Pradesh | Court case (Original Suit) | Filed against the company by an individual | Pending |
Full case history
All 90 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Zoetis India Limited
Zoetis India Limited has 9 MSME Form 1 returns on record between 2020 and 2024, listing 35 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| J J Parikh Pharma Pvt Ltd | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Ishta Siddhi Vinayaka Pharma Private Limited | •••• | •••• | •••• |
| SD Cargo Private Limited | •••• | •••• | •••• |
| K R Logistics | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 9 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Zoetis India Limited
Zoetis India Limited has a workforce of 127 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Zoetis India Limited
Zoetis India Limited has 27 board changes on record since 2008: 3 appointments and 24 cessations. The latest: Ashwini Shrikant Deshpande was appointed as Managing Director on 30 Sep 2023.
29 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Zoetis India Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Zoetis India Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Zoetis India Limited
Zoetis India has 10 GST registrations: 1 active and 9 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCE8269K1Z5 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Zoetis India Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Zoetis India Limited
Frequently Asked Questions about Zoetis India Limited
Zoetis India is an active public limited company based in Mumbai, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 06 September 2007 (19+ years old) and is registered under CIN U46497MH2007PLC203686.
Zoetis India reported revenue of ₹402.08 Cr for FY 2025 (up 30% YoY).
Zoetis India has 3 current directors:
- Ashwini Shrikant Deshpande - Managing Director
- Jaydip Chatterjee - Whole-Time Director
- Resha Mahabaleshwar Kantak - Whole-Time Director
Zoetis India reported a net profit of ₹28.72 Cr (net margin 7.1%) and EBITDA of ₹60.68 Cr (EBITDA margin 15.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Zoetis India is 18% over three years and 15% over five years. In the latest year (FY 2025) revenue rose 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Zoetis India is 27AABCE8269K1Z5, registered in Maharashtra. The company has 10 GST registrations in all, of which 1 is active and 9 are cancelled or inactive.
The CIN (Corporate Identification Number) of Zoetis India is U46497MH2007PLC203686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zoetis India has 90 court cases on record: 81 filed by the company and 8 filed against it. 6 are pending. Most are in the district courts.
Zoetis India was incorporated on 06 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Zoetis India has 5 deals on record (2 secondary share transfers, 2 acquisitions, 1 funding round), with disclosed funding of ₹6.58 Cr; the latest was in December 2012.
The peers of Zoetis India by revenue are Virbac Animal Health India Private Limited, Boehringer Ingelheim India Private Limited, Intervet India Private Limited, Natural Remedies Private Limited, Fredun Pharmaceuticals Ltd and 5 more, all in the Pharma industry (Animal Pharma).
Ashwini Shrikant Deshpande was appointed as Managing Director on 30 Sep 2023. Ashwini Shrikant Deshpande ceased to be Additional Director on 10 Mar 2023. Jaydip Chatterjee ceased to be Additional Director on 30 Sep 2022. Zoetis India has 27 board changes on record in total.